Mathijssen RHJ - Search Results

1

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients.

van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. van Dorst DCH, et al. Among authors: mathijssen rhj. Circ Res. 2021 Apr 2;128(7):1040-1061. doi: 10.1161/CIRCRESAHA.121.318051. Epub 2021 Apr 1. Circ Res. 2021. PMID: 33793337 Free PMC article. Review.

2

Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression.

Kappers MH, van Esch JH, Smedts FM, de Krijger RR, Eechoute K, Mathijssen RH, Sleijfer S, Leijten F, Danser AH, van den Meiracker AH, Visser TJ. Kappers MH, et al. J Clin Endocrinol Metab. 2011 Oct;96(10):3087-94. doi: 10.1210/jc.2011-1172. Epub 2011 Aug 3. J Clin Endocrinol Metab. 2011. PMID: 21816788

3

Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study.

Lankhorst S, Kappers MH, van Esch JH, Smedts FM, Sleijfer S, Mathijssen RH, Baelde HJ, Danser AH, van den Meiracker AH. Lankhorst S, et al. Hypertension. 2014 Dec;64(6):1282-9. doi: 10.1161/HYPERTENSIONAHA.114.04187. Epub 2014 Sep 2. Hypertension. 2014. PMID: 25185126

4

Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib.

Lankhorst S, Baelde HJ, Kappers MH, Smedts FM, Hansen A, Clahsen-van Groningen MC, Sleijfer S, Mathijssen RH, Danser AH, van den Meiracker AH. Lankhorst S, et al. Hypertension. 2015 Sep;66(3):543-9. doi: 10.1161/HYPERTENSIONAHA.115.05435. Epub 2015 Jul 20. Hypertension. 2015. PMID: 26195484

5

Sunitinib-induced blood pressure rise does not involve aldosterone: observations in a patient after bilateral adrenalectomy.

Versmissen J, van Doorn L, Mirabito Colafella KM, Mathijssen RH, Danser AHJ. Versmissen J, et al. J Hypertens. 2018 Nov;36(11):2279-2280. doi: 10.1097/HJH.0000000000001894. J Hypertens. 2018. PMID: 30256328 No abstract available.

6

Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?

van Dorst DCH, van Doorn L, Mirabito Colafella KM, Manintveld OC, Hassing HC, Danser AHJ, Mathijssen RHJ, Versmissen J. van Dorst DCH, et al. Among authors: mathijssen rhj. Clin Sci (Lond). 2021 Jul 30;135(14):1649-1668. doi: 10.1042/CS20200300. Clin Sci (Lond). 2021. PMID: 34283204 Review.

7

Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.

van Doorn L, Visser WJ, van Dorst DCH, Mirabito Colafella KM, Koolen SLW, de Mik AVE, Garrelds IM, Bovée DM, de Hoop EO, Bins S, Eskens FALM, Hoorn EJ, Jan Danser AH, Mathijssen RHJ, Versmissen J. van Doorn L, et al. Among authors: mathijssen rhj. Br J Cancer. 2023 Jan;128(2):354-362. doi: 10.1038/s41416-022-02036-6. Epub 2022 Nov 10. Br J Cancer. 2023. PMID: 36357702 Free PMC article.

8

Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort Study.

van Dorst DCH, Kabadayi S, Oomen-de Hoop E, Danser AHJ, Mathijssen RHJ, Versmissen J. van Dorst DCH, et al. Among authors: mathijssen rhj. J Am Heart Assoc. 2023 Jan 3;12(1):e028050. doi: 10.1161/JAHA.122.028050. Epub 2022 Dec 30. J Am Heart Assoc. 2023. PMID: 36583425 Free PMC article.

9

Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment.

van Dorst DCH, Mirabito Colafella KM, van Veghel R, Garrelds IM, de Vries R, Mathijssen RHJ, Danser AHJ, Versmissen J. van Dorst DCH, et al. Among authors: mathijssen rhj. Eur J Pharmacol. 2024 Jan 5;962:176199. doi: 10.1016/j.ejphar.2023.176199. Epub 2023 Nov 27. Eur J Pharmacol. 2024. PMID: 38029870 Free article.

10

The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer.

Buijs SM, van Dorst DCH, Kruip MJHA, van den Akker RFP, Cheung KL, Porrazzo R, Oomen-de Hoop E, Jager A, Koolen SLW, Versmissen J, Jan Danser AH, Versteeg HH, Bos MHA, Mathijssen RHJ. Buijs SM, et al. Among authors: mathijssen rhj. Biomed Pharmacother. 2024 Jan;170:115969. doi: 10.1016/j.biopha.2023.115969. Epub 2023 Dec 2. Biomed Pharmacother. 2024. PMID: 38042112 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page